About

Gutierrez-Ramos serves as Senior Vice President and Chief Science Officer of Danaher and is a named executive officer. His 2025 personal performance objectives centered on cost reductions, revenue, M&A, AI, innovation and R&D, together with qualitative goals relating to talent development, succession planning and sustainability.

Roles

Danaher Corp.
Senior Vice President & Chief Science Officer · Current role
2020–present
AbbVie, Inc.
Vice President – Drug Discovery · A biopharmaceutical company.
January 2020 – December 2020
AbbVie, Inc.
Global Head of Drug Discovery · Per Danaher's official leadership bio.
—
Pfizer Inc.
Group SVP, Biotherapeutics R&D · Per Danaher's official leadership bio.
—
GlaxoSmithKline
SVP and CEDD Head of Immuno-Inflammation · Per Danaher's official leadership bio.
—
Repertoire Immune Medicines
Founding CEO and President · Per Danaher's official leadership bio.
—
Synlogic
President and Chief Executive Officer · Per Danaher's official leadership bio.
—
Harvard Medical School
Assistant Professor of Genetics · Began his academic career here, per the official bio.
—

Fixed Compensation

FY 2025
Salary
$888,460
ComponentAnnual base salary
Bonus
$0
All other compensation
$97,016
Total compensation
$6,243,771

Performance Compensation

Data from FY 2025

Cash incentive

Annual cash incentive
$1,530,550
FormCash
Target Opportunity
—
Evaluation periodFY2025

Stock awards

Stock awards
$1,959,422
Formas disclosed
Vestingas disclosed

Also at Danaher Corp.

Colleague
Rainer M. Blair
President & Chief Executive Officer
Colleague
Feroz Dewan
Independent Director
Colleague
Linda Filler
Lead Independent Director

Related

Company
Danaher Corp.
Company hub

See how VectorShift works for your firm

Request Demo